On the pathway of an animal model for restless legs syndrome…
✍ Scribed by M. Manconi; W. Hutchins; T. R. Feroah; M. Zucconi; L. Ferini-Strambi
- Publisher
- Springer Milan
- Year
- 2007
- Tongue
- English
- Weight
- 145 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot
## Abstract Restless leg syndrome (RLS) is a major healthcare burden with increasing prevalence. It has been demonstrated that periodic limb movements (PLM) can occur as an isolated phenomenon, but they are often associated with this syndrome and are the only symptom of this disorder that can be me
## Abstract We examined 25 hyperlipidaemic patients with coronary heart disease undergoing regular low‐density lipoprotein apheresis (LA) treatment in weekly intervals. In this patient population, half were found to have concomitant restless legs syndrome (RLS). Laboratory investigations suggest th
## Abstract We developed and validated a standardized test procedure to evaluate the accuracy of the supportive diagnostic criterion “response to dopaminergic treatment” in restless legs syndrome (RLS). Forty‐eight patients who fulfilled at least three of the four essential criteria for RLS, thus i
## Abstract Only in the last three decades, the restless legs syndrome (RLS) has been examined in randomized controlled trials. The __Movement__ Disorder Society (MDS) commissioned a task force to perform an evidence‐based review of the medical literature on treatment modalities used to manage pati